North America Infectious Diseases Diagnostics Market is projected to reach USD 7
Posted by rohan on November 15th, 2017
North America Infectious Diseases Diagnostics Market Size is anticipated to grow at a 7.34% CAGR from 2016 to 2021 and it is estimated that the North America market was valued at USD 5.49 billion in 2016 and is relied upon to achieve USD 7.82 billion by 2021.Infectious disease diagnostics involves various method to check for the presence of foreign antigen/organism with the help of numerous diagnostic tools. Infectious disease conditions are highly widespread in under developed regions owing to the lack of awareness for personal hygiene, minimal health care expenditures, and absence of efficient physician services. Rising cases of infectious diseases in developed economies is further expected to boost the market growth. This has lead vitro diagnostic device manufacturers to invest into emerging economies. These companies are taking efforts to develop and commercialize cost effective tools for the infectious disease diagnosis.
Disease diagnostics are used for confirmation of a disease in form of a quick, precise test result. Being time consuming, disease diagnostics are on a rise. The infectious disease epidemics are spreading worldwide, thereby leading to an increase in demand of diagnostic tests. In addition, the incidences of malaria, flu, AIDS, and other diseases are also on a rise, creating a robust demand for infectious disease diagnostics. With a majority of physicians adopting the evidence-based treatment method, infectious disease diagnostic kits are more likely to gain traction over the forecast period. Several government-funded programs all over the globe are increasingly providing free screening and tests in order to increase awareness, accurately diagnose diseases, and minimize the chances of infection. Such initiatives are anticipated to boost the market growth in the next few years. However, diagnostic kits are expensive and manufacturers still have a poor distribution channel for operating across emerging economies. These two factors are projected to be the key challenges to rapid revenue growth of the global infectious diseases diagnostics market.
North America Infectious Diseases Diagnostics Market Segmentation by Product, Application, Technology and End User. On the basis of Product, it is segmented into Instruments, Reagents, Services, and Software. Consumables accounted for the largest share. On the basis of Application, it is segmented into Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), human papillomavirus (HPV), Methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola, Typhoid, Malaria, and Dengue) included. Hospital-acquired MRSA infections and human papillomavirus (HPV) are expected to be the fastest-growing market segments in the forecast period. On the basis of technology, it is segmented into PCR, INAAT, DNA Sequencing and Hybridization. Traditional methods are categorized into immunodiagnostics, microscopy, and biochemical characterization. Microarrays and INAAT are projected to witness the highest growth during the forecast period. This noteworthy growth can be accredited to the specificity and an increase in the efficiency of these tests. On the basis of End User, it is segmented into Hospital and Laboratories. Hospital laboratories and reference labs held the largest share in this market segment.
Key points from TOC:
Get free sample report @ http://marketdataforecast.com/market-reports/north-america-infectious-diseases-diagnostics-market-4608/request-sample
North America Infectious Diseases Diagnostics Market geographical segmentation by U.S. and Canada. North America held the largest share of the IDD market. This region is projected to witness a single-digit growth rate during the coming years due to growing adoption of premium diagnostic techniques that would sustain the market share of infectious disease diagnostics in developed region.
Scope of the report:
The major North America Infectious Diseases Diagnostics Market leaders are Abbott Laboratories, bioMérieux SA, Hologic, Inc., Danaher Corporation, SBecton, Dickinson and Company, Cepheid, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Like it? Share it!
About the Authorrohan
Joined: September 20th, 2017
Articles Posted: 1,346
More by this author